Pharmafile Logo
Pharmafocus logo
Advanced Search

MPs

Showing 7 posts of 7 posts found.

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019
Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …

News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

News
Ian Read

Science left behind in Pfizer-AstraZeneca saga

May 18, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science

With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …

News
nhs_parliament_2

Survey: free NHS in ‘jeopardy’

March 31, 2014
Sales and Marketing Hunt, MPs, NHS, coalition, confederation

A survey commissioned by the NHS Confederation suggests that nearly half of UK MPs believe an NHS which is free …

News

MPs concerned about care.data

February 27, 2014
Medical Communications, Sales and Marketing Dorrell, HSCIC, MPs, NHS, UK, care data, care.data, data

MPs have expressed concerns about security in the delayed NHS care.data programme which will see medical information routinely swapped between …

News
roche

MPs: trial transparency ‘unacceptable’

September 17, 2013
Medical Communications, Research and Development, Sales and Marketing MPs, Roche, Tamiflu, trial transparency

News

MPs find NHS bodies still blocking treatments

June 25, 2012
Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra

The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026